chitosan has been researched along with Intraocular Pressure in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 23 (71.88) | 24.3611 |
| 2020's | 6 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso, VN; Castilho, RO; Cronemberger, S; Faraco, AAG; Fernandes, SOA; Ferreira, AJ; Foureaux, G; Franca, JR; Fuscaldi, LL; Nogueira, JC; Ribeiro, TG; Yoshida, MI | 1 |
| Cheng, T; Cheng, Y; Li, J; Qu, Y; Zhang, X | 1 |
| Dangi, JS; Dubey, V; Kesavan, K; Mohan, P | 1 |
| Chi, J; Han, B; Hu, H; Jiang, Z; Liu, W; Wang, S; Yang, C | 1 |
| Augsburger, JJ; Banerjee, RK; Caixeta Faraj, RQ; Correa, ZM; Manna, S; Nair, V; Rao, MB; Riemann, B; Riemann, CD | 1 |
| Choy, YB; Ha, A; Kim, DW; Kim, SN; Kim, YJ; Kim, YK; Min, CH; Park, KH; Park, M | 1 |
| Castillo, AL; Cubillan, LDP; Macabeo, APG; Rubenicia, AML; Sicam, VADP; Villaflores, OB | 1 |
| Han, Y; Lin, Q; Liu, S; Wang, Y; Zhao, X | 1 |
| Kandasamy, R; Muthusamy, S; Natesan, S; Palanichamy, R; Pandian, S; Ponnusamy, C | 1 |
| Han, B; Jiang, Z; Liu, W; Peng, X; Qiao, J; Qiao, X; Yang, C | 1 |
| Han, B; Jiang, X; Liu, W; Peng, Y; Yang, C | 1 |
| Chen, Y; Gui, R; Hou, D; Li, J; Ping, Q; Tao, Q; Tian, S; Yang, F; Zang, L; Zhao, Y | 1 |
| Abd-Elsalam, WH; ElKasabgy, NA | 1 |
| Dhyanandhan, G; Jain, K; Kumar, RS; Sood, S | 1 |
| Haniuda, H; Ito, K; Kashiwagi, K; Ohtsubo, S; Takeoka, S | 1 |
| Ali, A; Ali, J; Bhatnagar, A; Kumar, N | 1 |
| Chen, M; Duan, L; Ge, J; Huang, L; Li, X; Ma, J; Quan, D; Xi, L; Zhang, W; Zhang, Z | 1 |
| Cardoso, VN; Castilho, RO; Cronemberger, S; Faraco, AA; Fernandes, SO; Ferreira, AJ; Foureaux, G; Franca, JR; Fulgêncio, Gde O; Fuscaldi, LL; Nogueira, JC; Ribeiro, TG; Yoshida, MI | 1 |
| Cheng, YH; Chien, CS; Chiou, SH; Chiu, AW; Jhan, YY; Liu, CJ; Tsai, KL; Tsai, TH | 1 |
| Li, J; Liu, D; Pan, H; Pan, W; Tan, G; Yang, X; Yu, S; Yuan, K | 1 |
| Li, J; Liu, W; Wang, J; Yin, Z; Zhao, R; Zhu, Y | 1 |
| Abd-Elgawad, AH; El-Dahan, MS; Jablonski, MM; Maria, DN; Soliman, OA | 1 |
| Filipović-Grcić, J; Hafner, A; Lovrić, J; Pepić, I; Pirkić, B | 1 |
| CAI, X; CHEN, RF; CHENG, LZ; FAN, JZ; GUO, H; LAN, YQ; YANG, LQ; ZHANG, LM; ZHOU, HS | 1 |
| Shinde, UA; Singh, KH | 1 |
| Aburahma, MH; Mahmoud, AA | 1 |
| Cunha-Júnior, Ada S; Faraco, AG; Fulgêncio, Gde O; Ribeiro, RR; Viana, FA; Yoshida, MI | 1 |
| Lai, JY | 1 |
| Chang, PC; Lin, HR | 1 |
| Wang, R; Yang, H; Zhang, XN | 1 |
| Gu, Q; Wang, R; Yang, H; Zhang, X | 1 |
| Cai, JP; Cheng, JW; Gu, QS; Hou, CL; Li, Y; Wang, WB; Wei, RL | 1 |
1 trial(s) available for chitosan and Intraocular Pressure
| Article | Year |
|---|---|
Intraocular pressure and endothelium cell counts after cataract surgery with chitosan and sodium hyaluronate (Healon GV): 3-year follow-up results of a randomised clinical trial.
Topics: Aged; Aged, 80 and over; Cell Count; Chitosan; Double-Blind Method; Endothelium, Corneal; Female; Humans; Hyaluronic Acid; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Tonometry, Ocular; Viscoelastic Substances | 2008 |
31 other study(ies) available for chitosan and Intraocular Pressure
| Article | Year |
|---|---|
Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation.
Topics: Animals; Cellulose; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Eye; Glaucoma; Intraocular Pressure; Male; Ophthalmic Solutions; Polymers; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Tissue Distribution | 2019 |
Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
Topics: Administration, Ophthalmic; Animals; Biological Availability; Blood-Retinal Barrier; Chitosan; Coated Materials, Biocompatible; Disease Models, Animal; Drug Delivery Systems; Female; Fluorescent Dyes; Glucocorticoids; Intraocular Pressure; Intravitreal Injections; Liposomes; Ophthalmic Solutions; Papilledema; Rats; Rats, Inbred BN; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2019 |
Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
Topics: Animals; Biological Availability; Carbonic Anhydrase Inhibitors; Chitosan; Cornea; Drug Carriers; Drug Delivery Systems; Glaucoma; Intraocular Pressure; Nanocapsules; Nanoparticles; Ophthalmic Solutions; Particle Size; Pectins; Polyelectrolytes; Rabbits; Sulfonamides; Thiazines | 2020 |
A self-healing and injectable hydrogel based on water-soluble chitosan and hyaluronic acid for vitreous substitute.
Topics: Animals; Biocompatible Materials; Cell Line; Cell Survival; Chitosan; Female; Fibroblasts; Humans; Hyaluronic Acid; Hydrogels; Injections, Intraocular; Intraocular Pressure; Male; Mice; Rabbits; Rats; Rats, Sprague-Dawley; Solubility; Treatment Outcome; Vitrectomy; Vitreous Body; Water | 2021 |
Non-invasive evaluation of toxicity in vitreoretinal domain following insertion of sustained release methotrexate micro-implant.
Topics: Absorbable Implants; Animals; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Implants; Electroretinography; Immunosuppressive Agents; Intraocular Pressure; Intravitreal Injections; Methotrexate; Microscopy, Acoustic; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Retina; Slit Lamp Microscopy; Vitreous Body | 2021 |
Novel glaucoma model in rats using photo-crosslinked azidobenzoic acid-modified chitosan.
Topics: Animals; Chitosan; Disease Models, Animal; Glaucoma; Intraocular Pressure; Rats; Retinal Ganglion Cells | 2021 |
Intraocular Pressure Reduction Effect of 0.005% Latanoprost Eye Drops in a Hyaluronic Acid-Chitosan Nanoparticle Drug Delivery System in Albino Rabbits.
Topics: Animals; Antihypertensive Agents; Chitosan; Drug Delivery Systems; Hyaluronic Acid; Intraocular Pressure; Latanoprost; Nanoparticles; Ophthalmic Solutions; Prostaglandins F, Synthetic; Rabbits | 2021 |
Preparation of 5-fluorouracil loaded chitosan microtube via in situ precipitation for glaucoma drainage device application: in vitro and in vivo investigation.
Topics: Chitosan; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure | 2021 |
Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
Topics: Animals; Antioxidants; Chickens; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Intraocular Pressure; Nanoparticles; Osmolar Concentration; Particle Size; Polyethylene Glycols; Quercetin; Rabbits; Resveratrol; Spectroscopy, Fourier Transform Infrared; Stilbenes | 2017 |
Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery.
Topics: Animals; Anticoagulants; Biocompatible Materials; Chitosan; Drug Delivery Systems; Drug Liberation; Filtering Surgery; Glaucoma; Heparin; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Intraocular Pressure; Male; Materials Testing; Rabbits; Rats | 2017 |
The feasibility study of an in situ marine polysaccharide-based hydrogel as the vitreous substitute.
Topics: Alginates; Animals; Aquatic Organisms; Cell Death; Cell Line; Chitosan; Electroretinography; Endothelial Cells; Endothelium, Corneal; Feasibility Studies; Fibroblasts; Fundus Oculi; Hydrogels; Intraocular Pressure; Male; Mice; Polysaccharides; Rabbits; Retinal Pigment Epithelium; Rheology | 2018 |
Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
Topics: Administration, Topical; Animals; Aqueous Humor; Bentonite; Betaxolol; Cell Survival; Chitosan; Cornea; Delayed-Action Preparations; Dialysis; Drug Carriers; Drug Delivery Systems; Drug Liberation; Epithelial Cells; Glaucoma; Humans; Intraocular Pressure; Nanoparticles; Ophthalmic Solutions; Particle Size; Rabbits; Static Electricity | 2018 |
Mucoadhesive olaminosomes: A novel prolonged release nanocarrier of agomelatine for the treatment of ocular hypertension.
Topics: Acetamides; Adhesives; Administration, Ophthalmic; Amines; Animals; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hexoses; Intraocular Pressure; Male; Ocular Hypertension; Oleic Acid; Particle Size; Rabbits; Solubility | 2019 |
Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.
Topics: Administration, Ophthalmic; Animals; Antihypertensive Agents; Betaxolol; Chickens; Chitosan; Chorioallantoic Membrane; Drug Carriers; Drug Stability; Glaucoma; Intraocular Pressure; Male; Nanoparticles; Rabbits; Tears; Treatment Outcome | 2013 |
Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma.
Topics: Absorbable Implants; Alginates; Animals; Antihypertensive Agents; Aqueous Humor; Behavior, Animal; Chitosan; Cornea; Drug Delivery Systems; Glaucoma; Glucuronic Acid; Hexuronic Acids; Intraocular Pressure; Latanoprost; Nanostructures; Prostaglandins F, Synthetic; Rabbits; Rats; Rats, Sprague-Dawley | 2013 |
Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Topics: Adhesiveness; Animals; Carteolol; Chitosan; Cornea; Drug Carriers; Glaucoma; Hydroquinones; Intraocular Pressure; Mucous Membrane; Nanoparticles; Particle Size; Permeability; Rabbits; Radionuclide Imaging | 2014 |
CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
Topics: Alkylating Agents; Animals; Chitosan; Conjunctiva; Disease Models, Animal; Drug Carriers; Fibrosis; Glaucoma; Injections, Intraocular; Intraocular Pressure; Mitomycin; Postoperative Complications; Rabbits; Trabeculectomy; Wound Healing | 2014 |
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
Topics: Administration, Ophthalmic; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Calorimetry, Differential Scanning; Chitosan; Delayed-Action Preparations; Diminazene; Drug Evaluation, Preclinical; Enzyme Activation; Eye Proteins; Glaucoma; Hyaluronic Acid; Intraocular Pressure; Male; Microscopy, Electron, Scanning; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2015 |
Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment.
Topics: Administration, Topical; Animals; Aqueous Humor; Chitosan; Cornea; Drug Carriers; Drug Liberation; Glaucoma; Hydrogels; Intraocular Pressure; Latanoprost; Materials Testing; Prostaglandins F, Synthetic; Rabbits; Temperature | 2016 |
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Topics: Animals; Antihypertensive Agents; Chitosan; Drug Evaluation, Preclinical; Drug Liberation; Intraocular Pressure; Liposomes; Male; Ocular Hypertension; Particle Size; Permeability; Rabbits; Timolol; Tissue Distribution | 2017 |
Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
Topics: Animals; Antihypertensive Agents; Biocompatible Materials; Calorimetry, Differential Scanning; Chitosan; Cornea; Drug Delivery Systems; Intraocular Pressure; Nanoparticles; Particle Size; Rabbits; Timolol | 2017 |
Nimodipine Ophthalmic Formulations for Management of Glaucoma.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Ophthalmic; Animals; beta-Cyclodextrins; Chemistry, Pharmaceutical; Chitosan; Drug Liberation; Freeze Drying; Glaucoma; Hypromellose Derivatives; Intraocular Pressure; Mice, Inbred C57BL; Nimodipine; Ophthalmic Solutions | 2017 |
A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation.
Topics: Animals; Area Under Curve; Biological Availability; Caco-2 Cells; Chitosan; Dexamethasone; Humans; Intraocular Pressure; Micelles; Ophthalmic Solutions; Rabbits; Surface-Active Agents | 2010 |
Ophthalmic drug-loaded N,O-carboxymethyl chitosan hydrogels: synthesis, in vitro and in vivo evaluation.
Topics: Administration, Topical; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chitosan; Cicatrix; Conjunctiva; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Female; Filtering Surgery; Fluorouracil; Glaucoma; Hydrogels; In Vitro Techniques; Intraocular Pressure; Iridoid Glycosides; Iridoids; Male; Microscopy, Electron, Scanning; Rabbits; Spectroscopy, Fourier Transform Infrared; Wound Healing | 2010 |
Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Calorimetry, Differential Scanning; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Electrochemistry; Excipients; Eye; Freeze Drying; Intraocular Pressure; Irritants; Membranes; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Ophthalmic Solutions; Particle Size; Quinoxalines; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared | 2011 |
Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Topics: Absorbable Implants; Acrylic Resins; Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Alginates; Animals; Brimonidine Tartrate; Calorimetry, Differential Scanning; Cellulose; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Glaucoma; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Intraocular Pressure; Kinetics; Methylcellulose; Ophthalmic Solutions; Polymers; Polymethacrylic Acids; Polyvinyls; Povidone; Quinoxalines; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Calorimetry, Differential Scanning; Chitosan; Drug Delivery Systems; Eye; Intraocular Pressure; Male; Ophthalmic Solutions; Rabbits; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Timolol; Tissue Adhesives; Water | 2012 |
Biocompatibility of genipin and glutaraldehyde cross-linked chitosan materials in the anterior chamber of the eye.
Topics: Animals; Anterior Chamber; Biocompatible Materials; Chitosan; Cornea; Cross-Linking Reagents; Gene Expression Regulation; Glutaral; Inflammation; Interleukin-6; Intraocular Pressure; Iridoids; Prostheses and Implants; Rabbits | 2012 |
Novel pluronic-chitosan micelle as an ocular delivery system.
Topics: Administration, Ophthalmic; Adrenergic beta-Antagonists; Animals; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Delivery Systems; Intraocular Pressure; Materials Testing; Metipranolol; Micelles; Microscopy, Electron, Transmission; Nanostructures; Nephelometry and Turbidimetry; Ophthalmic Solutions; Particle Size; Poloxamer; Rabbits; Spectroscopy, Fourier Transform Infrared | 2013 |
[The effect of Chitosan on intraocular structure when filling in the vitreous cavity].
Topics: Animals; Chitosan; Ciliary Body; Cornea; Female; Injections, Intraocular; Intraocular Pressure; Lens, Crystalline; Male; Rabbits; Retina; Vitreous Body | 2005 |
Feasibility study of chitosan as intravitreous tamponade material.
Topics: Animals; Anterior Eye Segment; Aqueous Humor; Biocompatible Materials; Chitosan; Ciliary Body; Cornea; Feasibility Studies; Hemostatics; Injections; Interleukin-6; Interleukin-8; Intraocular Pressure; Lens, Crystalline; Nitric Oxide; Rabbits; Retina; Vitrectomy; Vitreous Body | 2008 |